METTL3 and breast carcinoma: Another study showed that METTL3 is highly expressed in clinical breast cancer samples and engages in a positive feedback loop, cooperated with HBXIP and let-7g miRNA (HBXIP/let-7g/METTL3/HBXIP), to accelerate proliferation in breast cancer.